January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...
(MENAFN- 3BL) June 8, 2026 /3BL/ - Medtronic, a global leader in healthcare technology, announced FDA 510(k) clearance of its NellcorTM pulse oximetry system with Nell-EQTM intelligent processor. The ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor pulse oximetry system with Nell-EQ intelligent processor.
This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results